Mepolizumab is prescribed for:
- Severe eosinophilic asthma
- Eosinophilic granulomatosis with polyangiitis (EGPA)
- Hypereosinophilic syndrome
- Chronic rhinosinusitis with nasal polyps
- Respiratory and immunologic conditions
Generic Name: Mepolizumab
Brand Names: Nucala
Mepolizumab is an anti-IL-5 biologic for severe eosinophilic asthma, EGPA, and hypereosinophilic syndrome.
Mepolizumab is prescribed for:
Common side effects:
Serious side effects:
Mepolizumab is a monoclonal antibody that binds to and neutralizes IL-5, reducing eosinophil production and survival.
First biologic approved for:
Administered as subcutaneous injection every 4 weeks.
Learn more at MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Asthma, a chronic lung disease, causes airway inflammation and narrowing, resulting in wheezing, coughing, and shortness of breath, triggered by allergens, irritants, infections, or stress.
Sinusitis involves sinus inflammation and blockage due to infections, allergies, or structural issues, causing facial pain, pressure, and congestion, often following colds or triggered by allergens.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Mepolizumab? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.